Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Spitzer, Philipp ^a   Condic, Mateja ^a   Herrmann, Martin ^a   Oberstein, Timo Jan ^a   Scharin Mehlmann, Marina ^a   Gilbert, Daniel F ^a   Friedrich, Oliver ^a   Grömer, Teja ^a   Kornhuber, Johannes ^a   Lang, Roland ^a   Maler, Juan Manuel ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; ANTIINFECTIVE AGENT; PEPTIDE FRAGMENT;

BACTERIUM; CANDIDA ALBICANS; CHEMISTRY; CLASSIFICATION; DRUG EFFECT; ENTEROCOCCUS FAECALIS; HUMAN; MICROBIAL VIABILITY; SCANNING ELECTRON MICROSCOPY; ULTRASTRUCTURE;

AMYLOID BETA-PEPTIDES; ANTI-INFECTIVE AGENTS; BACTERIA; CANDIDA ALBICANS; ENTEROCOCCUS FAECALIS; HUMANS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; PEPTIDE FRAGMENTS;

EID: 84987881593     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32228     Document Type: Article

References (54)

1. Chow, V. W., Mattson, M. P., Wong, P. C. & Gleichmann, M. An overview of APP processing enzymes and products. Neuromolecular Med 12, 1-12, doi: 10.1007/s12017-009-8104-z (2010).
2. Wiltfang, J. et al. Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem 81, 481-496 (2002).
3. Little, C. S. et al. Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae. Frontiers in aging neuroscience 6, 304, doi: 10.3389/fnagi.2014.00304 (2014).
4. Bermejo-Pareja, F., Antequera, D., Vargas, T., Molina, J. A. & Carro, E. Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. BMC Neurol 10, 108, doi: 10.1186/1471-2377-10-108 (2010).
5. Takata, M. et al. Detection of amyloid beta protein in the urine of Alzheimer's disease patients and healthy individuals. Neurosci Lett 435, 126-130, doi: 10.1016/j.neulet.2008.02.019 (2008).
6. Tharp, W. G. & Sarkar, I. N. Origins of amyloid-beta. BMC Genomics 14, 290, doi: 10.1186/1471-2164-14-290 (2013).
7. Sevalle, J. et al. Aminopeptidase A contributes to the N-terminal truncation of amyloid beta-peptide. J Neurochem 109, 248-256, doi: 10.1111/j.1471-4159.2009.05950.x (2009).
8. Takeda, K., Araki, W., Akiyama, H. & Tabira, T. Amino-truncated amyloid beta-peptide (Abeta5-40/42) produced from caspasecleaved amyloid precursor protein is deposited in Alzheimer's disease brain. FASEB J 18, 1755-1757, doi: 10.1096/fj.03-1070fje (2004).
9. Bien, J. et al. The metalloprotease meprin beta generates amino terminal-truncated amyloid beta peptide species. J Biol Chem 287, 33304-33313, doi: 10.1074/jbc.M112.395608 (2012).
10. Haass, C. Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. Embo J 23, 483-488 (2004).
11. Maler, J. M. et al. Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species. Proteomics 7, 3815-3820, doi: 10.1002/pmic.200700311 (2007).
12. Guntert, A., Dobeli, H. & Bohrmann, B. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain. Neuroscience 143, 461-475 (2006).
13. Portelius, E. et al. Identification of novel APP/Abeta isoforms in human cerebrospinal fluid. Neurodegener Dis 6, 87-94, doi: 10.1159/000203774 (2009).
14. Schluesener, H. J., Su, Y., Ebrahimi, A. & Pouladsaz, D. Antimicrobial peptides in the brain: neuropeptides and amyloid. Front Biosci (Schol Ed) 4, 1375-1380 (2012).
15. Kagan, B. L. et al. Antimicrobial properties of amyloid peptides. Mol Pharm 9, 708-717, doi: 10.1021/mp200419b (2012).
16. Soscia, S. J. et al. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5, e9505, doi: 10.1371/journal.pone.0009505 (2010).
17. Izadpanah, A. & Gallo, R. L. Antimicrobial peptides. J Am Acad Dermatol 52, 381-390; quiz 391-382, doi: 10.1016/j.jaad.2004.08.026 (2005).
18. Kagan, B. L. Mode of action of yeast killer toxins: channel formation in lipid bilayer membranes. Nature 302, 709-711 (1983).
19. Zaiou, M. Multifunctional antimicrobial peptides: therapeutic targets in several human diseases. J Mol Med (Berl) 85, 317-329, doi: 10.1007/s00109-006-0143-4 (2007).
20. Kriz, Z., Klusak, J., Kristofikova, Z. & Koca, J. How ionic strength affects the conformational behavior of human and rat beta amyloids - a computational study. PLoS One 8, e62914, doi: 10.1371/journal.pone.0062914 (2013).
21. Wise-Scira, O., Xu, L., Kitahara, T., Perry, G. & Coskuner, O. Amyloid-beta peptide structure in aqueous solution varies with fragment size. J Chem Phys 135, 205101, doi: 10.1063/1.3662490 (2011).
22. Miklossy, J. Emerging roles of pathogens in Alzheimer disease. Expert Rev Mol Med 13, e30, doi: 10.1017/S1462399411002006 (2011).
23. Gorr, S. U., Sotsky, J. B., Shelar, A. P. & Demuth, D. R. Design of bacteria-agglutinating peptides derived from parotid secretory protein, a member of the bactericidal/permeability increasing-like protein family. Peptides 29, 2118-2127, doi: 10.1016/j. peptides.2008.09.019 (2008).
24. Torrent, M., Pulido, D., Nogues, M. V. & Boix, E. Exploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregation. PLoS Pathog 8, e1003005, doi: 10.1371/journal.ppat.1003005 (2012).
25. Renggli, S., Keck, W., Jenal, U. & Ritz, D. Role of autofluorescence in flow cytometric analysis of Escherichia coli treated with bactericidal antibiotics. J Bacteriol 195, 4067-4073, doi: 10.1128/JB.00393-13 (2013)
26. Bayles, K. W. Bacterial programmed cell death: making sense of a paradox. Nature reviews. Microbiology 12, 63-69, doi: 10.1038/ nrmicro3136 (2014).
27. Gilbert, D. F., Meinhof, T., Pepperkok, R. & Runz, H. DetecTiff: a novel image analysis routine for high-content screening microscopy. J Biomol Screen 14, 944-955, doi: 10.1177/1087057109339523 (2009).
28. Condic, M. et al. N-truncation and pyroglutaminylation enhances the opsonizing capacity of Abeta-peptides and facilitates phagocytosis by macrophages and microglia. Brain Behav Immun, doi: 10.1016/j.bbi.2014.05.003 (2014).
29. Thal, D. R., Ghebremedhin, E., Haass, C. & Schultz, C. UV light-induced autofluorescence of full-length Abeta-protein deposits in the human brain. Clin Neuropathol 21, 35-40 (2002).
30. Chan, F. T. et al. Protein amyloids develop an intrinsic fluorescence signature during aggregation. The Analyst 138, 2156-2162, doi: 10.1039/c3an36798c (2013).
31. Mercatelli, R. et al. Clasmatodendrosis and beta-amyloidosis in aging hippocampus. FASEB J 30, 1480-1491, doi: 10.1096/fj.15-275503 (2016).
32. Schlenzig, D. et al. Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry 48, 7072-7078, doi: 10.1021/bi900818a (2009).
33. Pike, C. J., Overman, M. J. & Cotman, C. W. Amino-terminal deletions enhance aggregation of beta-amyloid peptides in vitro. The Journal of biological chemistry 270, 23895-23898 (1995).
34. Meral, D. & Urbanc, B. Discrete molecular dynamics study of oligomer formation by N-terminally truncated amyloid beta-protein. J Mol Biol 425, 2260-2275, doi: 10.1016/j.jmb.2013.03.010 (2013).
35. Schilling, S. et al. On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45, 12393-12399, doi: 10.1021/bi0612667 (2006).
36. Kumar, D. K. et al. Amyloid-beta peptide protects against microbial infection in mouse and worm models of Alzheimer's disease. Sci Transl Med 8, 340ra372, doi: 10.1126/scitranslmed.aaf1059 (2016).
37. Nguyen, K. & Rabenstein, D. L. Interaction of the Heparin-Binding Consensus Sequence of beta-Amyloid Peptides with Heparin and Heparin-Derived Oligosaccharides. The journal of physical chemistry. B 120, 2187-2197, doi: 10.1021/acs.jpcb.5b12235 (2016).
38. Cardin, A. D. & Weintraub, H. J. Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9, 21-32 (1989).
39. Klajnert, B., Cortijo-Arellano, M., Bryszewska, M. & Cladera, J. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases. Biochem Biophys Res Commun 339, 577-582, doi: 10.1016/j. bbrc.2005.11.053 (2006).
40. McLaurin, J., Franklin, T., Zhang, X., Deng, J. & Fraser, P. E. Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. European journal of biochemistry/FEBS 266, 1101-1110 (1999).
41. Krut, J. J. et al. Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections. J Neurol 260, 620-626, doi: 10.1007/s00415-012-6688-y (2013).
42. Mattsson, N. et al. Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol 10, 51, doi: 10.1186/1471-2377-10-51 (2010).
43. Sjogren, M., Gisslen, M., Vanmechelen, E. & Blennow, K. Low cerebrospinal fluid beta-amyloid 42 in patients with acute bacterial meningitis and normalization after treatment. Neurosci Lett 314, 33-36, doi: S0304394001022856 [pii] (2001).
44. McManus, R. M., Higgins, S. C., Mills, K. H. & Lynch, M. A. Respiratory infection promotes T cell infiltration and amyloid-beta deposition in APP/PS1 mice. Neurobiol Aging 35, 109-121, doi: 10.1016/j.neurobiolaging.2013.07.025 (2014).
45. Andras, I. E. & Toborek, M. Amyloid beta accumulation in HIV-1-infected brain: The role of the blood brain barrier. IUBMB Life 65, 43-49, doi: 10.1002/iub.1106 (2013).
46. Mawanda, F. & Wallace, R. Can Infections Cause Alzheimer's Disease? Epidemiol Rev, doi: 10.1093/epirev/mxs007 (2013).
47. Itzhaki, R. F. Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus. Frontiers in aging neuroscience 6, 202, doi: 10.3389/fnagi.2014.00202 (2014).
48. Pisa, D., Alonso, R., Rabano, A., Rodal, I. & Carrasco, L. Different Brain Regions are Infected with Fungi in Alzheimer's Disease. Scientific reports 5, 15015, doi: 10.1038/srep15015 (2015).
49. Nasoohi, S., Hemmati, A. A., Moradi, F. & Ahmadiani, A. The gamma-secretase blocker DAPT impairs recovery from lipopolysaccharide-induced inflammation in rat brain. Neuroscience 210, 99-109, doi: 10.1016/j.neuroscience.2012.02.051 (2012).
50. Spitzer, P. et al. Phagocytosis and LPS alter the maturation state of b-amyloid precursor protein and induce different Ab peptide release signatures in human mononuclear phagocytes. Journal of neuroinflammation 7, 59 (2010).
51. Bitting, L., Naidu, A., Cordell, B. & Murphy, G. M. Beta-amyloid peptide secretion by a microglial cell line is induced by betaamyloid-( 25-35) and lipopolysaccharide. The Journal of biological chemistry 271, 16084-16089 (1996).
52. Monning, U. et al. Synthesis and secretion of Alzheimer amyloid beta A4 precursor protein by stimulated human peripheral blood leucocytes. FEBS Lett 277, 261-266, doi: 0014-5793(90)80861-C [pii] (1990).
53. Dominguez, D. et al. Phenotypic and biochemical analyses of BACE1-and BACE2-deficient mice. J Biol Chem 280, 30797-30806, doi: 10.1074/jbc.M505249200 (2005).
54. Itzhaki, R. F. et al. Microbes and Alzheimer's Disease. J Alzheimers Dis 51, 979-984, doi: 10.3233/JAD-160152 (2016).